Add Company
Join Now

ILC Therapeutics Revenue and Competitors

License our Company Data API

Glasgow, uk

Location

N/A

Total Funding

Pharma

Industry

Employee Data

  • ILC Therapeutics has 7 Employees.(i)
  • ILC Therapeutics grew their employee count by -12% last year.

ILC Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Senior ScientistReveal Email/Phone
5
Laboratory TechnicianReveal Email/Phone
6
Research associateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M26510%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M4752%N/AN/A
#4
$20.9M893%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M62-67%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M369%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is ILC Therapeutics?

ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy.\n\nILC Therapeutic’s platform approach has produced two first-in-class lead candidates, Alfacyte™ and Dermacyte™ focused on antiviral and dermatological indications respectively, which are progressing towards the clinic.

keywords:N/A

N/A

Total Funding

7

Number of Employees

N/A

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M7-12%N/A
#2
$1.6M7-59%N/A
#3
$1.5M7-12%N/A
#4
N/A814%N/A
#5
N/A80%N/A